Pharmacological Characteristics of Receptor-operated and Potential-operated Ca2+ Channels in Rat Aorta
Overview
Authors
Affiliations
In the rat aorta activation of the potential-operated Ca2+ channels by 100 mM K+ resulted in a greater 45Ca2+ influx than stimulation of the receptor-operated Ca2+ channels by norepinephrine (NE, 3 X 10(-7) M) or angiotensin II (AII, 10(-7) M). 45Ca2+ influx induced by NE was inhibited by prazosin (10(-7) M) but not by yohimbine (10(-6) M) while that by AII was abolished by [Sar1, Ile8]AII (10(-8) M). These receptor antagonists had no effect on the 45Ca2+ influx produced by K+. Bay k 8644 enhanced the influxes to low concentrations of NE and K+ while it was additive with the maximal concentration of NE but not with K+. 3-Isobutyl-1-methyl-xanthine and forskolin inhibited both the influx and efflux of 45Ca2+ elicited by NE but were ineffective against those caused by K+. Nifedipine blocked the efflux of 45Ca2+ induced by K+ but not that evoked by NE. However, both types of Ca2+ channel exhibited the same sensitivity to inhibition by Ca2+ entry blockers (nifedipine/verapamil) on 45Ca2+ influxes. These data suggest that in the rat aorta, the receptor-operated calcium channels and potential-operated calcium channels share similar structural characteristics. However, they are gated separately and distinctly by their respective activators.
L.: A Review on Ethnopharmacology, Phytochemistry, and Cardiovascular Benefits.
Mahleyuddin N, Moshawih S, Ming L, Zulkifly H, Kifli N, Loy M Molecules. 2022; 27(1).
PMID: 35011441 PMC: 8747064. DOI: 10.3390/molecules27010209.
Zinc ions block the intracellular calcium release induced by caffeine in guinea-pig taenia caeci.
Nasu T Experientia. 1995; 51(2):113-6.
PMID: 7875248 DOI: 10.1007/BF01929351.
Freslon J Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(6):670-6.
PMID: 3444482 DOI: 10.1007/BF00165759.
Thoolen M, Miller C, Chiu A, Timmermans P Cardiovasc Drugs Ther. 1987; 1(4):377-83.
PMID: 2908713 DOI: 10.1007/BF02209079.
Topouzis S, Pelton J, Miller R Br J Pharmacol. 1989; 98(2):669-77.
PMID: 2684314 PMC: 1854727. DOI: 10.1111/j.1476-5381.1989.tb12642.x.